Comparative Analysis of RT-PCR and a Colloidal Gold Immunochromatographic Assay for SARS-CoV-2 Detection
Diagnostics · 28.05.2025 · 15 (11) · 1362
DOI: 10.3390/diagnostics15111362 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 28.05.2025. Verfasst von Hui Li und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology & Clinical Laboratories, NewYork-Presbyterian Queens, 56-45 Main Street Flushing, New York, NY 11355, USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Background/Objectives: The COVID-19 pandemic has highlighted the urgent need for rapid, accurate, and accessible diagnostic testing to effectively manage and contain the spread of SARS-CoV-2. RT-PCR is widely recognized as the gold standard for SARS-CoV-2 detection due to its high sensitivity and specificity. However, RT-PCR testing requires specialized laboratory equipment, highly trained personnel, and extended processing times, which limits its feasibility for large-scale screening and point-of-care applications. This study aims to systematically evaluate the diagnostic performance of RT-PCR and a colloidal gold immunochromatographic assay (GICA).
Methods
By comparing these two methods, we seek to determine a GICA’s effectiveness as a complementary or alternative diagnostic tool, particularly in resource-limited settings and scenarios requiring rapid, large-scale testing. We assessed the following key clinical parameters: sensitivity, specificity, NPV, PPV, and accuracy. Additionally, we investigated the correlation between GICA signal intensity and RT-PCR Ct values using regression analysis, receiver operating characteristic curve analysis, and the calculated area under the curve.
Results
Our findings indicate that while RT-PCR exhibits superior sensitivity, GICA results demonstrate a strong correlation with RT-PCR results and provide a rapid, cost-effective alternative for SARS-CoV-2 detection. Unlike RT-PCR, which requires extensive resources and prolonged turnaround times, a GICA delivers results within 20 min, making it a viable option for decentralized testing and real-time public health interventions.
Conclusions
These results suggest that a GICA can serve as a complementary diagnostic tool alongside RT-PCR, particularly in resource-limited settings and high-throughput screening scenarios. By integrating GICAs into broader testing strategies, healthcare systems can enhance early detection efforts, improve accessibility to diagnostics, and strengthen pandemic response measures.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology & Clinical Laboratories, NewYork-Presbyterian Queens, 56-45 Main Street Flushing, New York, NY 11355, USA.
- Clinical Laboratory, The Second Affiliated Hospital of Guangzhou Medical University, 250 Changgang East Road Zhuhai District, Guangzhou 510260, China.
- Department of Quality, Patient Safety and Regulatory Affairs, NewYork-Presbyterian Queens, 56-45 Main Street Flushing, New York, NY 11355, USA.
- Weil Cornell Medical College, 1300 York Avenue, New York, NY 10065, USA.
- Division of Infectious Disease, NewYork-Presbyterian Queens, 56-45 Main Street Flushing, New York, NY 11355, USA.
- Department of Pathology & Laboratory Medicine, Weil Cornell Medical College, 1300 York Avenue, New York, NY 10065, USA.
ORCID-Profile: Dakai Liu, Nishant Prasad
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- NIH HHS
- Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the National Institutes of Health
- Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD–PhD Program
- F30 Predoctoral Fellowship from the National Institutes of Health
Zitieren
APA
Li, H., Liu, D., Zhou, Q., Rodriguez, G. D., Pietz, H., Singh, V., Konadu, E., James, K. K., Lui, C., Shao, M., Chen, J., Schreiner, A., Urban, C., Truong, J., Prasad, N., & Rodgers, W. H. (2025). Comparative Analysis of RT-PCR and a Colloidal Gold Immunochromatographic Assay for SARS-CoV-2 Detection. Diagnostics, 15(11), 1362. https://doi.org/10.3390/diagnostics15111362
Vancouver
Li H, Liu D, Zhou Q, Rodriguez GD, Pietz H, Singh V, et al. Comparative Analysis of RT-PCR and a Colloidal Gold Immunochromatographic Assay for SARS-CoV-2 Detection. Diagnostics. 2025;15(11):1362. doi:10.3390/diagnostics15111362
BibTeX
@article{Li2025,
author = {Li, Hui and Liu, Dakai and Zhou, Qiang and Rodriguez, George D and Pietz, Harlan and Singh, Vishnu and Konadu, Eric and James, Keither K and Lui, Calvin and Shao, Mingyu and Chen, Junyu and Schreiner, Andrew and Urban, Carl and Truong, James and Prasad, Nishant and Rodgers, William Harry},
title = {Comparative Analysis of RT-PCR and a Colloidal Gold Immunochromatographic Assay for SARS-CoV-2 Detection},
journal = {Diagnostics},
year = {2025},
volume = {15},
number = {11},
pages = {1362},
doi = {10.3390/diagnostics15111362}
}
EUVIMED